DPP4i has also been demonstrated to increase the expression of vasoactive intestinal peptide (VIP) in ischemia-reperfusion injury in mouse orthotopic lung transplants [17] and inhibit xanthine oxidase activity to generate ROS in an LPS-sepsis model [18]. The gene discussed is VIP; the disease is Sepsis.